Single-dose ticagrelor does not prolong the QT interval in healthy subjects

替卡格雷 QT间期 莫西沙星 安慰剂 医学 加药 置信区间 麻醉 交叉研究 药效学 分析灵敏度 心脏病学 急性冠脉综合征 内科学 药理学 药代动力学 心肌梗塞 病理 替代医学 抗生素 微生物学 生物
作者
Kathleen Butler,Wei Cui,Rongyue Teng
出处
期刊:International Journal of Clinical Pharmacology and Therapeutics [Dustri-Verlag]
卷期号:48 (10): 643-651 被引量:10
标识
DOI:10.5414/cpp48643
摘要

Ticagrelor (AZD6140), the first reversibly binding oral platelet P2Y12 receptor inhibitor, is currently under development for reduction of thrombotic events in patients with acute coronary syndrome (ACS).This study was designed to assess the potential effects of a single oral dose of ticagrelor on QT interval.In this randomized, double-blind, double-dummy, placebo- and positive-controlled, three-way crossover study, 36 healthy males received single doses of ticagrelor 900 mg, moxifloxacin (positive control) 400 mg, or placebo in three treatment periods. This ticagrelor dose is substantially higher than the proposed therapeutic dose (90 mg twice daily after a 180 mg loading dose). QT intervals were assessed from 12-lead digital electrocardiogram (ECG) recordings over 24 h. Plasma levels of ticagrelor and its major metabolite AR-C124910XX were measured. Exploratory analyses of exposure-QTc interval relationships were conducted. Safety assessments were made throughout the study.Mean QTcX, QTcF, and QTcB intervals were similar between ticagrelor and placebo. All point estimates for comparisons between ticagrelor and placebo in QTcX over 24 h post dosing were < 5 milliseconds and all upper confidence limits (UCL) from two-sided 95% confidence intervals were < 10 milliseconds (maximum time-matched mean effect 2.27 milliseconds with UCL 6.05 milliseconds at 12 h). With moxifloxacin, all point estimates and UCLs (except at 24 h post dose) were > 5 milliseconds and > 10 milliseconds, respectively, versus placebo; indicating the study had sufficient sensitivity to detect clinically meaningful changes in QT interval. There was no apparent relationship between ticagrelor or AR-C124910XX levels and QT intervals. Ticagrelor was well tolerated at the tested dose.A single oral dose of 900 mg ticagrelor did not prolong the QT interval in healthy volunteers compared with placebo. Thus, it is expected that ticagrelor will not affect cardiac repolarization in ACS patients.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
喷火的小火龙完成签到 ,获得积分10
1秒前
shiyi0709发布了新的文献求助200
4秒前
十一苗完成签到 ,获得积分10
4秒前
5秒前
杨三完成签到 ,获得积分10
8秒前
刘亮亮完成签到,获得积分10
14秒前
胖胖橘完成签到 ,获得积分10
15秒前
甜蜜的夕阳完成签到,获得积分10
18秒前
wuxinrong完成签到 ,获得积分10
22秒前
NCYN完成签到 ,获得积分10
23秒前
慈祥的鸿煊完成签到 ,获得积分10
24秒前
刻苦的新烟完成签到 ,获得积分0
25秒前
阚雨函完成签到 ,获得积分10
26秒前
Elena完成签到 ,获得积分20
28秒前
going完成签到 ,获得积分10
30秒前
yanmh完成签到,获得积分10
30秒前
33秒前
青山完成签到 ,获得积分10
35秒前
37秒前
37秒前
刘mou完成签到 ,获得积分10
39秒前
小格格完成签到,获得积分10
40秒前
爆米花的应助被Brave采纳,获得10
41秒前
李爱国的应助被Elena采纳,获得30
41秒前
ice发布了新的文献求助10
43秒前
坚强夜梦完成签到,获得积分10
44秒前
包子完成签到 ,获得积分10
46秒前
kyle完成签到,获得积分10
46秒前
lt0217完成签到,获得积分10
48秒前
多边形完成签到 ,获得积分10
50秒前
77小姐完成签到 ,获得积分10
51秒前
俭朴映寒完成签到,获得积分10
55秒前
Sweety_完成签到 ,获得积分10
55秒前
柒柒球完成签到 ,获得积分10
56秒前
小川完成签到 ,获得积分10
56秒前
冷傲的孤晴完成签到,获得积分10
57秒前
57秒前
千柳完成签到 ,获得积分10
58秒前
Pigmentuman完成签到,获得积分10
59秒前
xyzlancet完成签到,获得积分10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180068
求助须知:如何正确求助?哪些是违规求助? 9570224
关于积分的说明 21808724
捐赠科研通 7776054
什么是DOI,文献DOI怎么找? 3433261
关于科研通互助平台的介绍 2557425
邀请新用户注册赠送积分活动 2479012